They have been extensively studied and shown to provide significant weight loss benefits
Glucagon-like peptide-1 receptor (GLP-1R) agonists are a group of drugs that targets incretin hormone action, and its receptors are widely distributed in nerves, islets, heart, lung, skin, and other organs
Mild redness, slight swelling, or brief itching are common and typically harmless
Rapid weight reductioncommon in the first months of treatment with these medicationsmay not allow sufficient time for physiological adaptation
The concern is during induction of anesthesia, patients could have significant food or liquids in the stomach due to gastroparesis
The GLP-1 receptor component drives appetite suppression and slows gastric emptying effects that are shared with semaglutide and tirzepatide